ERCC1 as Predictor of Platinum Benefit in Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

ERCC1 as Predictor of Platinum Benefit in Non–Small-Cell Lung Cancer

Published:2017-02-01 Issue:4 Volume:35 Page:384-386
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Postel-Vinay Sophie¹,Soria Jean-Charles¹

Affiliation:

1. Sophie Postel-Vinay and Jean-Charles Soria, Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Paris-Saclay University, and INSERM, UMR981, Villejuif, France

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.70.5053

Reference27 articles.

1. The potential of exploiting DNA-repair defects for optimizing lung cancer treatment

2. ERCC1 and RRM1: Ready for Prime Time?

3. DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

4. Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein‐Protein Interaction;ChemMedChem;2024-03-05

2. DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort study;Translational Lung Cancer Research;2022-12

3. Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification;Cancer Research;2022-02-16

4. Synergistic effects of olaparib combined with ERCC1 on the sensitivity of cisplatin in non‑small cell lung cancer;Oncology Letters;2021-03-10

5. Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy;ESMO Open;2021-02